IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v18y2021i14p7349-d591370.html
   My bibliography  Save this article

Associations between Biomarkers of Exposure and Lung Cancer Risk among Exclusive Cigarette Smokers in the Golestan Cohort Study

Author

Listed:
  • Brian L. Rostron

    (Center for Tobacco Products, Food and Drug Administration, Silver Spring, MD 20993, USA)

  • Jia Wang

    (Center for Tobacco Products, Food and Drug Administration, Silver Spring, MD 20993, USA)

  • Arash Etemadi

    (Metabolic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    Digestive Oncology Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran 1411713135, Iran)

  • Sapna Thakur

    (Center for Tobacco Products, Food and Drug Administration, Silver Spring, MD 20993, USA)

  • Joanne T. Chang

    (Center for Tobacco Products, Food and Drug Administration, Silver Spring, MD 20993, USA)

  • Deepak Bhandari

    (Division of Laboratory Sciences, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA)

  • Julianne Cook Botelho

    (Division of Laboratory Sciences, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA)

  • Víctor R. De Jesús

    (Division of Laboratory Sciences, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA)

  • Jun Feng

    (Division of Laboratory Sciences, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA)

  • Mitchell H. Gail

    (Biostatistics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA)

  • Maki Inoue-Choi

    (Metabolic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA)

  • Reza Malekzadeh

    (Digestive Oncology Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran 1411713135, Iran)

  • Akram Pourshams

    (Digestive Oncology Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran 1411713135, Iran)

  • Hossein Poustchi

    (Liver and Pancreaticobilliary Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran 1411713135, Iran)

  • Gholamreza Roshandel

    (Golestan Research Center of Gastroenterology and Hepatology, Golestan University of Medical Sciences, Gorgan 4917867439, Iran)

  • Meredith S. Shiels

    (Infections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20892, USA)

  • Qian Wang

    (Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA)

  • Yuesong Wang

    (Division of Laboratory Sciences, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA)

  • Baoyun Xia

    (Division of Laboratory Sciences, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA)

  • Paolo Boffetta

    (Stony Brook Cancer Center, Stony Brook University, Stony Brook, NY 11794, USA
    Department of Medical and Surgical Sciences, University of Bologna, 40138 Bologna, Italy)

  • Paul Brennan

    (International Agency for Research on Cancer, 69372 Lyon, France)

  • Christian C. Abnet

    (Metabolic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA)

  • Antonia M. Calafat

    (Division of Laboratory Sciences, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA)

  • Lanqing Wang

    (Division of Laboratory Sciences, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA)

  • Benjamin C. Blount

    (Division of Laboratory Sciences, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA)

  • Neal D. Freedman

    (Metabolic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA)

  • Cindy M. Chang

    (Center for Tobacco Products, Food and Drug Administration, Silver Spring, MD 20993, USA)

Abstract

Biomarkers of tobacco exposure are known to be associated with disease risk but previous studies are limited in number and restricted to certain regions. We conducted a nested case–control study examining baseline levels and subsequent lung cancer incidence among current male exclusive cigarette smokers in the Golestan Cohort Study in Iran. We calculated geometric mean biomarker concentrations for 28 matched cases and 52 controls for the correlation of biomarker levels among controls and for adjusted odds’ ratios (ORs) for lung cancer incidence by biomarker concentration, accounting for demographic characteristics, smoking quantity and duration, and opium use. Lung cancer cases had higher average levels of most biomarkers including total nicotine equivalents (TNE-2), 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL), and 3-hydroxyfluorene (3-FLU). Many biomarkers correlated highly with one another including TNE-2 with NNAL and N-Acetyl-S-(2-cyanoethyl)-L-cysteine (2CYEMA), and N-Acetyl-S-(4-hydroxy-2-buten-1-yl)-L-cysteine (t4HBEMA) with N-Acetyl-S-(3-hydroxypropyl-1-methyl)-L-cysteine (3HMPMA) and N-Acetyl-S-(4-hydroxy-2-methyl-2-buten-1-yl)-L-cysteine (4HMBEMA). Lung cancer risk increased with concentration for several biomarkers, including TNE-2 (OR = 2.22, 95% CI = 1.03, 4.78) and NNN (OR = 2.44, 95% CI = 1.13, 5.27), and estimates were significant after further adjustment for demographic and smoking characteristics for 2CYEMA (OR = 2.17, 95% CI = 1.03, 4.55), N-Acetyl-S-(2-carbamoylethyl)-L-cysteine (2CAEMA) (OR = 2.14, 95% CI = 1.01, 4.55), and N-Acetyl-S-(2-hydroxypropyl)-L-cysteine (2HPMA) (OR = 2.85, 95% CI = 1.04, 7.81). Estimates were not significant with adjustment for opium use. Concentrations of many biomarkers were higher at the baseline for participants who subsequently developed lung cancer than among the matched controls. Odds of lung cancer were higher for several biomarkers including with adjustment for smoking exposure for some but not with adjustment for opium use.

Suggested Citation

  • Brian L. Rostron & Jia Wang & Arash Etemadi & Sapna Thakur & Joanne T. Chang & Deepak Bhandari & Julianne Cook Botelho & Víctor R. De Jesús & Jun Feng & Mitchell H. Gail & Maki Inoue-Choi & Reza Malek, 2021. "Associations between Biomarkers of Exposure and Lung Cancer Risk among Exclusive Cigarette Smokers in the Golestan Cohort Study," IJERPH, MDPI, vol. 18(14), pages 1-12, July.
    • Handle: RePEc:gam:jijerp:v:18:y:2021:i:14:p:7349-:d:591370
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/18/14/7349/pdf
    Download Restriction: no
    File URL: https://www.mdpi.com/1660-4601/18/14/7349/
    Download Restriction: no
    ---><---

    More about this item

    Keywords

    tobacco; biomarker; lung cancer;
    All these keywords.

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:18:y:2021:i:14:p:7349-:d:591370. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.